The liquid embolic agent market is projected to grow from USD 283.4 million in 2025 to USD 727.8 million by 2035, at a CAGR of 9.9%. Cyanoacrylates will dominate with a 43.0% market share, while arteriovenous malformations (avm) will lead the application outlook segment with a 46.7% share.